After undergoing treatment for Stage 2 Hodgkins lymphoma, Hardee Bhavsar is on a journey to cross items off her bucket list ...

A rare case highlights Guillain-Barré syndrome as the first sign of Hodgkin’s lymphoma, emphasizing the need to consider malignancy in unexplained or refractory neuropathies.

In the global intention-to-treat population, Pola-R-CHP showed significant progression-free survival benefit over R-CHOP ...

Two Kansas City-area men are suing Monsanto and Bayer, alleging they developed cancer from using Roundup weed killer.

Ciltacabtagene autoleucel (cilta-cel; Carvykti) for multiple myeloma has a new boxed warning for immune effector ...

Missouri’s highest court refused to review a ruling that found the herbicide causes cancer. Parent company Bayer says it is ...

From his work at IMG Academy to being a GM with TBT’s Sideline Cancer, Coach Clapper’s one-day camp for high school players ...

Several pharmaceutical companies showcased data on their BTK inhibitors at the ASCO 2023 conference, including Ono ...

MIT and Harvard scientists have designed an advanced type of immune cell called a CAR-NK cell that can destroy cancer while ...